These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8804728)

  • 21. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH; Nelson DL
    Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    Pinto W; Battaglia G
    Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioural and autoradiographic study.
    Moorman JM; Leslie RA
    Neuropharmacology; 1998; 37(3):357-74. PubMed ID: 9681934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoradiographic mapping of brain 5-HT2A binding sites in P and in AA alcohol-preferring rats.
    Ciccocioppo R; Ge J; Barnes NM; Cooper SJ
    Brain Res Bull; 1997; 44(1):33-7. PubMed ID: 9288829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible blockade of high-affinity choline uptake in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Vickroy TW; Malphurs WL
    Biochem Pharmacol; 1994 Sep; 48(6):1281-7. PubMed ID: 7945422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone.
    Zhang L; Ma W; Barker JL; Rubinow DR
    Neuroscience; 1999; 94(1):251-9. PubMed ID: 10613515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment.
    Battaglia G; Norman AB; Creese I
    J Pharmacol Exp Ther; 1987 Oct; 243(1):69-75. PubMed ID: 2889827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional differences in reappearance of D2-dopamine receptors in the rat caudate-putamen complex after irreversible inactivation.
    Loopuijt LD; Sebens JB; Korf J
    Brain Res; 1988 Jul; 456(2):263-70. PubMed ID: 2974747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin.
    Anji A; Kumari M; Sullivan Hanley NR; Bryan GL; Hensler JG
    Neuropharmacology; 2000 Aug; 39(11):1996-2005. PubMed ID: 10963743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299.
    Stenfors C; Werner T; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):500-7. PubMed ID: 9650801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018 and its metabolite, in rat brain.
    Takahashi Y; Kusumi I; Ishikane T; Koyama T
    J Neural Transm (Vienna); 1998; 105(2-3):181-91. PubMed ID: 9660096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
    Ribas C; Miralles A; Escribá PV; García-Sevilla JA
    Eur J Pharmacol; 1998 Jun; 351(1):145-54. PubMed ID: 9698216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic toluene exposure on central monoamine and peptide receptors and their interactions in the adult male rat.
    von Euler G; Fuxe K; Hansson T; Ogren SO; Agnati LF; Eneroth P; Härfstrand A; Gustafsson JA
    Toxicology; 1988 Nov; 52(1-2):103-26. PubMed ID: 2847366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.